Huaxia Ophthalmology announced that the actual controller, chairman and general manager, Mr. Su Qingcan, plans to increase the company's shares through centralized bidding from September 2, 2026 to December 1, 2026, with an increase of no less than RMB 30 million. There is no price range for this plan to increase holdings; the funding source is own funds.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.